Marqeta, Inc. Stock 12‑Month Price Target Cut to $20, Implies 12% Upside

What happened

Estimates from nine analysts put Marqeta’s average 12-month share-price target at $20, down from $20.28, with individual targets ranging from $18 to $25. Based on the November 3 closing price, the $20 target implies about 12% potential upside. The consensus rating remains Hold among 14 analysts.

Confirmed

Global impact / market context

The lower average target signals that the analysts providing price estimates have become slightly less optimistic, although their $20 target still implies potential upside from the cited closing price. A Hold consensus suggests the group, overall, is not calling for a clear buy or sell decision.

Analyst inference

The article reports two different analyst group sizes: nine analysts contributed price targets, while 14 analysts contributed ratings. Those measures describe expectations rather than company results, and the reported 12% upside is tied specifically to the November 3 closing price, not a guaranteed return.

Confirmed

What to watch

1. Watch for changes in the average target and the $18-to-$25 forecast range; a wider spread would indicate less agreement among analysts about Marqeta’s potential share value. Analyst inference
2. Track whether the 14-analyst rating mix changes from three Buys, 10 Holds, and one Sell, since a shift would alter the reported consensus view. Analyst inference
3. Compare future target updates with the share price used at the time; the stated 12% potential upside is based on the November 3 closing price. Confirmed

Evidence

• Original source link unavailable